12 Best Artificial Intelligence Stocks Under $50 According to Analysts

Page 11 of 11

1. Tempus AI Inc. (NASDAQ:TEM)

Share Price as of January 5: $38.25

Average Upside Potential as of January 5: 47.71%

Number of Hedge Fund Holders: 7

Tempus AI Inc. (NASDAQ:TEM) is a healthcare technology company that provides services like advanced molecular diagnostics, access to a vast de-identified clinical and molecular data library, and AI-powered analytical tools. Its customer base includes healthcare providers, pharmaceutical companies, and researchers.

The company is growing by using AI to analyze medical information. To support this growth, the Centers for Medicare & Medicaid Services (CMS) approved reimbursement for assessments of cardiac dysfunction using the Tempus ECG-AF algorithm. This increases the accessibility and adoption of the company’s AI-powered technology, contributing to a projected $700 million in total revenue for 2024, which represents a 32% growth year-over-year.

Tempus AI Inc. (NASDAQ:TEM) also announced agreements with major insurers like Blue Cross Blue Shield, which means patients with insurance plans can access AI-enabled molecular profiling services easily and potentially reduce the cost of care. This showcases the company’s commitment to making innovative technologies widely available and improving healthcare outcomes for a larger population.

As we acknowledge the growth potential of Tempus AI Inc. (NASDAQ:TEM), our conviction lies in the belief that AI stocks hold great promise for delivering high returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than TEM but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 11 of 11